Location History:
- Martinsried, DE (2021)
- Munich, DE (2021 - 2024)
Company Filing History:
2 out of 2 
1 out of 1,777 
1 out of 1 Years Active: 2021-2024
Title: Andrea Hawe: Innovator in Pharmaceutical Formulations
Introduction
Andrea Hawe is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of treatments involving glucagon-like peptide 1 (GLP-1) and monoclonal antibodies. With a total of 5 patents to her name, her work has had a substantial impact on medical science.
Latest Patents
Among her latest patents, Andrea has developed methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof. This innovation provides stable liquid formulations of GLP-1 and GLP-1 analogues, along with methods for using these formulations in the treatment of various disorders or conditions. Additionally, she has created a lyophilized formulation of a monoclonal antibody against transthyretin. This invention offers antibody formulations and methods that are useful for the prophylaxis or treatment of transthyretin-related amyloidosis.
Career Highlights
Throughout her career, Andrea has worked with notable companies such as Rose Pharma LLC and Novo Nordisk A/S. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Andrea has collaborated with talented individuals in her field, including Eva Keilhauer and Olimpia Popko. These partnerships have fostered a creative environment that has led to significant advancements in their respective areas of research.
Conclusion
Andrea Hawe's contributions to pharmaceutical formulations and her innovative patents highlight her role as a leading inventor in the industry. Her work continues to influence the development of effective treatments for various medical conditions.